 0 Table of Contents |
  1 Home |
  2 Background |
  3 Laboratory Report scenarios |
  4 Managing Laboratory Report statuses |
  5 Design choices |
  6 Challenges |
  7 Implementation notes |
  8 Certified reference material |
  9 Downloads |
  10 eHN guideline data set |
  11 Authors and contributors |
  12 Obligations |
  13 Known Issues |
  14 Copyright |
  15 Cross-version Analysis |
  16 Dependencies |
  17 Mapping to Profiles |
   17.1 EHDS Laboratory Report Mapping |
   17.2 EHDS Laboratory Observation Mapping |
   17.3 EHDS ServiceRequest Mapping |
   17.4 EHDS Specimen Mapping |
   17.5 EHDS MedicationAdministration Mapping |
   17.6 EHDS Device Mapping |
   17.7 EHDS Attachment Mapping |
   17.8 EHDS RelatedPerson Mapping |
  18 Artifacts Summary |
   18.1 Actor Laboratory Report Consumer |
   18.2 Actor Laboratory Report Creator |
   18.3 Actor Laboratory Report Repository |
   18.4 Human Name Obligations |
   18.5 Observation Obligations |
   18.6 Patient Obligations |
   18.7 ServiceRequest Obligations |
   18.8 Specimen Obligations |
   18.9 Bundle: Laboratory Report |
   18.10 Composition: Laboratory Report |
   18.11 DiagnosticReport: Laboratory Report |
   18.12 Observation Results: laboratory |
   18.13 Patient: Animal |
   18.14 ServiceRequest: Laboratory Order |
   18.15 Specimen: Laboratory |
   18.16 Substance: Specimen Additive Substance |
   18.17 Quantity (Eu Lab) |
   18.18 Range (Eu Lab) |
   18.19 Ratio (Eu Lab) |
   18.20 Certified Reference Material: CodeableConcept |
   18.21 Certified Reference Material: Identifier |
   18.22 Device Laboratory Test Kit |
   18.23 Document DiagnosticReport Reference |
   18.24 Laboratory Certified Reference Material |
   18.25 Laboratory Code |
   18.26 Laboratory Code: LOINC |
   18.27 Laboratory Code: NPU |
   18.28 Laboratory Order |
   18.29 Laboratory Report Types |
   18.30 Laboratory Specialty |
   18.31 Laboratory Study Types |
   18.32 Laboratory Techniques |
   18.33 Specimen Additive |
   18.34 Specimen Container |
   18.35 Specimen Types |
   18.36 Types of species |
   18.37 Laboratory Code: example |
   18.38 Bundle: converted from CDA |
   18.39 Bundle: Hepatitis Panel |
   18.40 Bundle: Microbiology Culture + Susceptibility |
   18.41 Bundle: MyHealth@EU Proof Of Concept |
   18.42 Bundle: two sections |
   18.43 Composition: example |
   18.44 DiagnosticReport: example |
   18.45 Observation: Aerobic Culture example |
   18.46 Observation: Anaerobic Culture example |
   18.47 Observation: certified reference material |
   18.48 Observation: Gram Staining example |
   18.49 Observation: Gram-positive cocci example |
   18.50 Observation: Gram-positive cocci, observed quantity, example |
   18.51 Observation: Leukocytes Presence example |
   18.52 Observation: ratio example |
   18.53 Observation: Staphylococcus aureus Cephalothin susceptibility example |
   18.54 Observation: Staphylococcus aureus Growth example |
   18.55 Observation: Staphylococcus aureus identified example |
   18.56 Observation: Staphylococcus aureus levoFLOXacin susceptibility example |
   18.57 Observation: Staphylococcus aureus Oxacillin susceptibility example |
   18.58 Observation: Staphylococcus aureus susceptibility panel example |
   18.59 Observation: Staphylococcus aureus Vancomycin susceptibility example |
   18.60 Patient: animal example |
   18.61 Patient: Dutch complete name |
   18.62 Patient: example |
   18.63 Practitioner: example |
   18.64 PractitionerRole: example |
   18.65 ServiceRequest: example |
   18.66 Specimen: animal example |